← Back
Fund FOMO or FUD

Hedge funds cut BMY holdings by 60.93%

Hedge funds holding Bristol Myers Squibb Co. (BMY) reduced their aggregate position by 79.124 million shares between 03/31/2026 and 06/30/2026.
By
The essentials
  • Thirty-eight funds held BMY in the 06/30/2026 13F filings.
  • Seven funds increased their positions, while 17 reduced holdings.
  • GenTrust LLC exited BMY as of 06/30/2026.

Fund managers rethink BMY exposure

The latest 13F filings for the reporting period ending June 30, 2026, indicate a significant shift in hedge fund exposure to Bristol Myers Squibb Co. (Symbol: BMY). Among the 90 most recent hedge fund filers analyzed, 38 maintained stakes in the pharmaceutical company as of June 30.

Of those 38 funds, seven increased their holdings in BMY between the March 31, 2026, and June 30 reporting periods. Meanwhile, 17 funds cut their stake in the company. Notably, GenTrust LLC fully exited its position in BMY common stock by the June 30 reporting date, marking one of the most significant shifts among the group.

Aggregate share count drops sharply

When considering the broader landscape of 4,372 hedge funds examined, the total number of BMY shares held by funds declined sharply between the two periods. From 129,868,616 shares on March 31, 2026, the collective position shrank to 50,744,561 shares by June 30, a reduction of 79,124,055 shares. This represents a drop of approximately 60.93% in hedge fund exposure to BMY over the quarter.

The report did not specify the identities of the three top funds holding the most BMY shares on June 30. However, the Nasdaq analysis highlights how tracking changes in share counts across groups of funds between reporting periods can provide valuable insight into market sentiment. It can also reveal potential investment opportunities.

13F data has limitations but still offers insight

It is important to acknowledge the constraints of 13F filings. These reports only capture long positions held by hedge funds. They do not include any information about short sales or hedging strategies. For example, a fund may appear to be bullish on BMY in its 13F filing by showing a long position. It could simultaneously maintain a bearish stance through short calls or other derivative instruments. This hidden bearish activity remains invisible to the public.

Despite these limitations, the report emphasizes that analyzing trends in share ownership among groups of funds can still yield meaningful patterns. In the case of BMY, the near two-thirds reduction in hedge fund holdings between the two reporting periods suggests a clear shift in sentiment. It warrants further investigation for investors seeking actionable stock ideas.

Between the lines

The 60.93% drop in BMY holdings signals a shift in confidence among hedge fund managers, even if the full picture is not in public view.

Frequently asked questions

How many funds held BMY in the 06/30/2026 13F filings?

Ninety most recent 13F filings were analyzed, and 38 of them held Bristol Myers Squibb Co. (BMY) by the end of June 2026.

What was the biggest change in BMY holdings?

The largest change was the exit of GenTrust LLC. The overall aggregate share count held by hedge funds fell by 79.124 million shares, representing a 60.93% decline.

Why should investors look at 13F filings?

According to the Nasdaq report, 13F filings can help investors understand broader market sentiment, even though they only show long positions and miss shorts.

Based on reporting by Nasdaq, compiled by the Tradingbird newsroom. Published 06 Aug 2026, 23:45.
Topics: Policy · Stocks

Related

Down with old blame, up with new facts · Markets ·

NY Sues Kalshi Over $36B in Illegal Gambling, Says Platform Violates State Law · Markets ·

HMRC scrutiny shakes Premier League transfer window · Markets ·

Warner Bros. Paramount merger trial pushed to March · Markets ·

Meta AI breaches another system · Markets ·

Read this in: English · Arabiy · Deutsch · Espanol · Italiano · Portugues · Russkij · Turkce